Tag Archives: Office of Inspector General
Inspector General Puts Forest CEO in the Crosshairs
Forest Laboratories’ CEO Howard Solomon was no doubt surprised to receive a form letter from the Office of Inspector General (OIG) on April 8, which, if acted upon, would exclude him from doing business with federal healthcare plans, including Medicare and Medicaid.
Solomon has 30 days to explain to the OIG why he should not be [...]
Posted in Strategy Also tagged Celexa, Forest Laboratories, Howard Solomon, Levothroid, Lexapro, Medicaid, Medicare Leave a comment

Comply or Die: Introducing GSK's New Corporate Integrity Agreement